covid
Buscar en
Endocrinología y Nutrición (English Edition)
Toda la web
Inicio Endocrinología y Nutrición (English Edition) Hypothyroidism and protein-losing enteropathy: A case report
Información de la revista
Vol. 63. Núm. 2.
Páginas 95-96 (febrero 2016)
Vol. 63. Núm. 2.
Páginas 95-96 (febrero 2016)
Scientific letter
Acceso a texto completo
Hypothyroidism and protein-losing enteropathy: A case report
Hipotiroidismo y enteropatía pierde-proteínas: a propósito de un caso
Visitas
7910
Irene Berges-Raso
Autor para correspondencia
inberges@tauli.cat

Corresponding author.
, Ismael Capel, Assumpta Caixàs, Roser Trallero, Mercedes Rigla
Servicio de Endocrinología y Nutrición, Hospital Universitario Parc Taulí, Sabadell, Barcelona, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo

We report the case of a 34-year-old female patient with a history of hypothyroidism, lymphangiectasia, and protein-losing enteropathy on treatment with levothyroxine (200μg/day) who attended the emergency room complaining of dyspnea and fever. A chest X-ray showed bilateral pleural effusion and enlarged cardiac silhouette, while echocardiography revealed pericardiac effusion with systolic–diastolic collapse of the right chambers. The results of laboratory tests performed were as follows: TSH, 21.3μU/mL (normal: 0.4–4); free thyroxine, 0.69ng/dL (normal: 0.8–1.8); triiodothyronine, 0.62pg/mL (normal: 2–4.4); serum albumin, 17.9g/L (normal: 34–48); prealbumin, 11.4mg/dL (normal: 20–40); total cholesterol, 118mg/dL (normal: 150–200); triglycerides, 100mg/dL (normal: 50–200); vitamin E 1.9μg/mL (normal: 5–20) (corrected for cholesterol and triglyceride levels of 0.89mg/g, in the lower limit of normal: normal: >0.8mg/g); vitamin A, 0.09mg/L (normal: 0.3–1); 25-OH vitamin D, <9ng/mL; copper, 70μg/dL (normal: 80–155); zinc 56μg/dL (normal: 68–107); and serum selenium, 44μg/dL (normal: 60–120).

Multifactorial pleural and pericardiac effusion in the setting of hypoproteinemia and hypothyroidism, with respiratory tract superinfection, was diagnosed, and was treated with evacuating pericardiocentesis, oxygen therapy, and intravenous ceftriaxone. Her weight during hospitalization was 70kg, and a low-fat diet was started (20–30g of lipids during her hospital stay), together with oral supplements to provide a total of 600kcal/day, with 27g of hydrolyzed protein and 22g of lipids, of which 15.4g were medium-chain triglycerides (MCTs). Thirty grams of oil with mCTs and supplements of vitamin A (50,000IU/day), E (200mg/24h), and D (10,000IU/week) were also added. Copper and zinc levels were considered moderately low in the context of the acute phase, and watchful waiting was decided upon. The patient reported good compliance with levothyroxine treatment, and low drug levels despite very high doses (approximately 2.8μg/kg/day) were therefore attributed to the underlying gastrointestinal disease. The dose was increased to 250μg/day. Some days later, the patient experienced a clinical improvement with decreased stool count and steatorrhea and was discharged.

At an outpatient monitoring visit at three months, her clinical condition was much improved. She weighed 70.3kg and reported a lower number of stools, with mild steatorrhea. She was still taking oral supplements, and laboratory tests showed an improvement in the nutritional parameters: prealbumin 18mg/dL and albumin 27.2g/L. Levels of copper 88μg/dL, serum selenium 60μg/L, vitamin A 0.5mg/L, and vitamin E 2.9μg/mL (corrected: 1.4mg/g) were normalized. The zinc level was 59μg/dL, and her vitamin D level continued to be less than 9ng/mL despite supplementation. Thyroid hormone levels had normalized (TSH 2.27μU/mL and free thyroxine 1.1ng/dL).

A review of the patient's clinical history during her hospitalization found that she was born with congenital lymphedema and intestinal lymphangiectasia that required surgery several times during childhood. However, she was not diagnosed with Hennekam syndrome until she was 28, based on dysmorphic signs and the delayed development of her daughter. Previously, at the age of 24, she had experienced pleuropericarditis in the context of myxedema with 226μU/mL of TSH and 0.06ng/dL of free T4. Subsequently, patient monitoring was irregular, but the levothyroxine dose was increased to 200μg/day, due to the difficulty in normalizing TSH.

Hennekam syndrome is an extremely uncommon cause of hypothyroidism characterized by congenital lymphedema, mainly affecting the limbs and genitalia, and developmental delay. It is also related to dysmorphic traits (flattened face, broad and flattened nasal bridge, and hypertelorism), glaucoma, hypoacusis, and dental and renal abnormalities. It is characterized by lymphangiectasia in the bowel, pleura, pericardium, thyroid gland, and kidney. An intestinal biopsy shows a dilation of lymphatic vessels in the lamina propria that leads to protein-losing enteropathy and malabsorption. Thyroid lymphangiectasia is the cause of hypothyroidism.1–5 This genetic condition was described by Hennekam in 1989.1 To our knowledge, 36 cases have been reported worldwide to date.1–5 This is the first case reported in Spain. Twenty-five percent of patients have autosomal recessive mutations in the CCBE1 gene, and more than 20% in the FAT4 gene. CCBE1 is a key gene for the development of lymphatic system. However, the relationship with FAT4 has not yet been elucidated.5 Other genes involved include VEGFR3 and GJC2.7 In this patient, diagnosis was initially based on the clinical history and phenotype.

Hypothyroidism occurring in this syndrome is difficult to manage due to decreased levothyroxine absorption secondary to intestinal lymphangiectasia, which may require very high thyroid hormone doses. The treatment of malabsorption syndromes depends on symptom severity. It usually consists of a low-fat, protein- and mCT-rich diet, in addition to supplements of lipid soluble vitamins and electrolytes. Home enteral nutrition by mouth or tube using products specifically designed for malabsorption syndromes (with fat mainly as mCTs and partially hydrolyzed protein) may sometimes be required. Subcutaneous octreotide treatment6 or parenteral nutrition may be required in very severe cases.7 If pleural or pericardiac effusion occurs, drainage may be needed. Lymphedema may be very disabling, requiring surgery and diuretics.2–4 Its prognosis is highly variable, and if severe complications occur, life expectancy may be decreased.2,5 Differential diagnosis includes other syndromes causing congenital lymphedema such as Noonan syndrome, Aagenaes cholestasis-lymphedema syndrome, Milroy's disease, or Turner syndrome.1,2,5

In conclusion, Hennekam syndrome is a rare cause of hypothyroidism and intestinal malabsorption secondary to lymphangiectasia that requires adequate nutritional treatment with low-fat diet, protein supplementation, and deficient lipid soluble vitamins, and careful, possibly high levothyroxine dosage.

Conflicts of interest

The authors state that they have no conflicts of interest.

References
[1]
R.C. Hennekam, R.A. Geerdink, B.C. Hamel, F.A. Hennekam, P. Kraus, J.A. Rammeloo, et al.
Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation.
Am J Med Genet, 34 (1989), pp. 593-600
[2]
I.D. Van Balkom, M. Alders, J. Allanson, C. Bellini, U. Frank, G. de Jong, et al.
Lymphedema–lymphangiectasia–mental retardation (Hennekam) syndrome: a review.
Am J Med Genet, 112 (2002), pp. 412-421
[3]
A. Ozyurt, E. Sevinc, A. Baykan, D. Arslan, M. Argun, O. Pamukcu, et al.
Variable clinical presentation in primary lymphoedema: report of two cases.
Clin Dysmorphol, 23 (2014), pp. 83-87
[4]
I. Elmansour, S. Chiheb, H. Benchikhi.
Hennekam syndrome: a rare cause of primary lymphedema.
Dermatol Online J, (2014), pp. 20
[5]
P. Frosk, B. Chodirker, L. Simard, W. El-Matary, A. Hanlon-Dearman, J. Schwartzentruber, et al.
A novel CCBE1 mutation leading to a mild form of Hennekam syndrome: case report and review of the literature.
BMC Med Genet, 16 (2015), pp. 28
[6]
S. Al Sinani, Y. Al Rawahi, H. Abdoon.
Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia.
World J Gastroenterol, 18 (2012), pp. 6333-6337
[7]
A. Amiot.
Protein-losing enteropathy.
Rev Med Interne, 36 (2015), pp. 467-473

Please cite this article as: Berges-Raso I, Capel I, Caixàs A, Trallero R, Rigla M. Hipotiroidismo y enteropatía pierde-proteínas: a propósito de un caso. Endocrinol Nutr. 2016;63:95–96.

Copyright © 2015. SEEN
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos